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Abstract
Introduction: Although coronary microembolization (CME) is a frequent phe-
nomenon in patients undergoing percutaneous coronary intervention, few data
are available on the changes in left ventricular ejection fraction (LVEF) and coro-
nary flow reserve (CFR) after CME.
Material and methods: In this study, six miniature swine of either sex (body
weight 21-25 kg) were used to prepare a CME model. After coronary angiogra-
phy, 1.2 × 105 microspheres (42 μm) were selectively infused into the left ante-
rior descending artery via an infusion catheter. Left ventricular ejection fraction
was evaluated using transthoracic echocardiography; myocardial blood flow was
measured using coloured microspheres; and CFR and coronary pressure were
measured using Doppler and a pressure wire.
Results: Left ventricular ejection fraction was 0.77 ±0.08 at baseline, 0.69 ±0.08
at 2 h, 0.68 ±0.08 at 6 h, and 0.76 ±0.06 at 1 week (2 h vs. baseline p < 0.05; 
6 h vs. baseline p < 0.01). After CME, left ventricular end systolic volume (LVESV)
and end diastolic volume (LVEDV) were significant larger 1 week later (p < 0.01
for both), while CFR was significantly reduced at 6 h (1.24 ±0.10 at 6 h vs. 1.77
±0.30 at baseline, p < 0.01) and myocardial blood flow remained unchanged.
Serum ET-1 level was significantly higher only at 6 h after CME (6 h vs. baseline
p < 0.05).
Conclusions: Reduction of CFR and LVEF is significant at 6 h after CME and recov-
ers 1 week later with left ventricular dilation.
Key words: coronary artery, microembolization, remodelling, left ventricular ejec-
tion fraction.
Introduction 
Coronary microembolization (CME), which is frequent in patients under-
going percutaneous coronary intervention (PCI) [1], potentially leads to per-
fusion-contraction mismatch, inflammation, and regional myocardial con-
tractile dysfunction in the absence of coronary artery stenosis [2-6]. Recent
magnetic resonance imaging (MRI) studies reported that left ventricular ejec-
tion fraction (LVEF) decreased at 6 h [7, 8], and then recovered spontaneously
one week after CME [4, 7]. Coronary flow reserve (CFR) [9-11] and coronary
artery blood pressure after CME rarely have been studied, and previous ani-
mal model studies used an open-chest approach which might affect haemo-
dynamics during model preparation. Therefore, in the present study, we
assessed the magnitude and potential underlying mechanisms of changes
in LVEF and CFR after CME using an animal model developed by our team.
Corresponding author:
Junbo Ge, MD, FESC, FACC,
FSCAI
Department of Cardiology
Zhongshan Hospital
Fudan University
and Shanghai Institute
of Cardiovascular Diseases
180 Fenglin Road
Shanghai 200032, China
Phone: 86-21-64041990,
ext. 2745
Fax: 86-21-64223006
E-mail: ge.junbo@
zs-hospital.sh.cn
Clinical research
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute 
of Cardiovascular Disease, Shanghai, China
Submitted: 27 August 2010
Accepted: 7 December 2010
Arch Med Sci 2012; 8, 1: 63-69
DOI: 10.5114/aoms.2012.27283
Copyright © 2012 Termedia & Banach64 Arch Med Sci 1, February / 2012
Jianying Ma, Juying Qian, Junbo Ge, Xin Zeng, Aijun Sun, Shufu Chang, Zhangwei Chen, Yunzeng Zou
Material and methods
Methods
The experimental protocols of this study were
approved by the Animal Care and Use Committee
of Fudan University, China. The animals were han-
dled according to the guidelines of the American
Physiological Society.
Six miniature swine of either sex (20-25 kg body
weight) were initially sedated with intramuscular
injection of a combination of ketamine (5-10 mg/kg)
and diazepam (5-10 mg/kg). Anaesthesia was main-
tained with 3% pentobarbital sodium intravenous-
ly (3 mg/kg/h) until the experiment was complet-
ed, and the animals were observed until awakening
and spontaneously breathing without intubation
was achieved. The swine were anaesthetized a sec-
ond time one wake later.
Study design
Echocardiography and CFR of all the six swine
studied were recorded and measured at baseline,
2 h, 6 h and 1 week later. Teichholtz formula was
used to calculate LVEF and left ventricular volume. 
Coronary microembolization methodology
The right femoral artery and vein were dissect-
ed; 7 F and 6 F vascular sheaths were placed in each
vessel, respectively. Prior to coronary cannulation,
animals were anticoagulated with intravenous
heparin: 5000 IU bolus followed by 100 IU/kg/h. For
coronary angiography, a 6 F XB 3.5 guiding catheter
was used for the left coronary artery system via the
femoral approach, and a 2.8 F infusion catheter
(Cordis Inc., Johnson&Johnson) was then placed in
the LAD artery between the second and third diag-
onal branches. Microembolization was induced by
manual continuous injection of 120,000 micros-
pheres (42 μm Dynospheres; Dyno Particles; Lille-
stro /m, Norway) into the LAD followed by a 6 ml
saline flush. Measurements of systemic haemody-
namics and myocardial function were repeated at
baseline, 2 h, 6 h and 1 week after CME. A blood
sample was drawn and serum was separated for
further analysis. Aortic pressure was monitored
through the guiding catheter.
Left ventricular ejection fraction measurement
by echocardiography
Animals were investigated in a right lateral posi-
tion. Transthoracic echocardiographic studies were
performed by one experienced investigator who
was blinded to the study protocol using a GE VIVID
7 system with a 1.5-4.3 MHz transducer. Two-dimen-
sional and M-mode imaging data were acquired
using a parasternal short-axis view at the level of
the papillary muscles and recorded on the video-
tape. Left ventricular ejection fraction, fractional
shortening (FS), left ventricular end systolic (LVESV)
and end diastolic (LVEDV) volumes were obtained
from M-mode echocardiography. 
Measurement of coronary flow reserve 
and coronary pressure
Coronary blood flow velocity and pressure were
determined with a Doppler flow guidewire (0.014-
inch, FlowWire® XT, Volcano) and a pressure wire
(0.014 inch, SmartWire, Volcano). Coronary pres-
sure and average peak flow velocity (APV) in the
LAD were recorded at rest and at hyperaemia
(18 mg adenosine). Coronary flow reserve (CFR) was
calculated as the ratio of hyperaemic/baseline APV
during hyperaemia. 
Measurement of myocardial blood flow before
and after coronary microembolization 
Quantification of regional myocardial blood flow
was evaluated at baseline, 2 h, 6 h and 1 week
using four different-coloured (yellow, red, blue, vio-
let) 15-μm microspheres (E-Z Trac corporation) [12].
For each measurement, 5 × 106 to 10 × 106 micro  -
spheres suspended in 6 ml of saline with 0.02%
Tween 80 (Sigma) were injected into the left ven-
tricle followed by a 10 ml saline flush. Withdrawal
of femoral arterial reference blood samples start-
ed 10 s before injection of the microspheres and
continued for 70 s at a rate of 5.4 ml/min (model
DDB-300; China). After the experiment, the heart
was removed and samples from the posterior and
anterior wall were taken for measurement of
regional blood flow. Tissue digestion, extraction of
the dye, and calculation of regional myocardial
blood flow were performed as described previous-
ly [12].
Measurement of serum monocyte chemotactic
protein-1 and endothelin-1 
Measurement of serum monocyte chemotactic
protein-1 (MCP-1) and endothelin-1 (ET-1) concen-
tration was performed using an ELISA kit from R&D
Company (USA). 
Postmortem analysis
The animals were euthanized by intravenous
injection of 30 ml of 10% potassium chloride. The
heart was removed and sectioned into 5 slices from
apex to base in a plane parallel to the atrioventric-
ular groove and immersed in a 0.2 mol/l sodium
phosphate buffer (pH 7.4) containing 1.0% nitrob-
lue tetrazolium chloride (NBT) (Sigma, Deisenhofen,
Germany) for 20 min at 37°C to identify infarcted
tissue. About 200 mg transmural tissue specimensArch Med Sci 1, February / 2012 65
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from the anterior walls (CME zone) and the poste-
rior walls (control) were taken and immediately
fixed in 4% buffered formaldehyde. The formalde-
hyde-fixed specimens were embedded in paraffin
and sectioned into 5-μm thick slices. Haematoxylin
and eosin (HE) staining was used to demonstrate
the presence of myocardial necrosis. Inflammatory
cells were counted in 10 fields of 190,000 μm2 each
from the microembolized and the control area. The
vast majority of inflammatory cells were polymor-
phonuclear leukocytes (PMN). 
TUNEL assays
Cardiomyocyte apoptosis was quantified by the
TdT-mediated dNTP Nick-End Labelling (TUNEL)
technique (R&D Company, USA). Formalin-fixed sec-
tions (5 μm) were treated with proteinase K 
(20 μg/ml) and then with 50 μl of reaction mix (TdT
dNTP mix (1 μl)) in the presence of 50× Mn2+ (1 μl),
TdT enzyme (1 μl) and 1×TdT Labeling Buffer (50 μl)
at 37°C. In each specimen, TUNEL-positive car-
diomyocyte nuclei were counted in 40 random high-
power fields (400×), and the percentage ratio of
TUNEL-positive cell nuclei to the total number of
cell nuclei was calculated.
Statistical analysis
Data are reported as mean ± standard deviation
(SD). Changes of haemodynamics, coronary flow
reserve, coronary pressure, average peak flow veloc-
ity at rest and hyperaemic and myocardial function
were compared using a general linear model of vari-
ance for repeated measures with SPSS 11.0 soft-
ware. A p value of < 0.05 was considered statisti-
cally significant. 
Results
As shown in Table I, systemic haemodynamics
remained stable throughout the experiment. Coro-
nary angiography showed that TIMI 3 flow was
maintained immediately after CME. 
Left ventricle size measured 
by echocardiography
After CME, LVEF progressively decreased at 2 h
and 6 h, and returned to baseline at 1 week. The
LVESV enlarged over time, with the difference
achieving statistical significance relative to base-
line at 2 h (p < 0.05), and the enlargement persist-
ing from 6 h to one week after CME (6 h vs. base-
line p < 0.05; 1 week vs. baseline p < 0.01). However,
LVEDV only was significantly increased vs. baseline
1 week (p < 0.01) after CME. The latter observations
suggest that LV dilation is continued from 6 h to 
1 week after CME despite LVEF recovery (Figures 1
and 2).
Changes of coronary flow reserve and pressure
Average base peak velocity did not differ
throughout the study. Average coronary hyperaemic
peak velocity significantly decreased from 16.80
±4.30 cm/s at baseline to 12.30 ±2.60 cm/s at 2 h
(p < 0.05); a further decrease in velocity was
observed at 6 h (16.80 ±4.30 cm/s at baseline vs.
10.20 ±1.90 cm/s at 6 h, p < 0.01). The CFR only was
significantly reduced at 6 h (1.24 ±0.10 at 6 h vs.
1.77 ±0.30 at baseline, p < 0.01). Coronary pressure
did not differ before and after CME, both at base-
line and hyperaemia (Table II). 
Changes of myocardial blood flow
Anterior subendocardial blood flow (ASBF) was
1.3 ±0.2 ml/min × g at baseline, 1.4 ±0.2 ml/min × g
at 2 h, 1.1 ±0.2 ml/min × g at 6 h and 1.3 ±0.3 ml/
min × g at 1 week after CME; posterior subendo-
cardial blood flow (PSBF) was 1.4 ±0.2 ml/min × g
at baseline, 1.3 ±0.2 ml/min × g at 2 h, 1.2 ±0.1 ml/
min × g at 6 h and 1.2 ±0.2 ml/min × g at 1 week
after CME. The ratio of ASBF to PSBF was 0.9 ±0.1
at baseline, 1.0 ±0.1 at 2 h, 1.1 ±0.3 at 6 h and 1.1
±0.3 at 1 week after CME (Figure 3). Although the
ratio of ASBF to PSBF slightly increased after CME,
there was no statistically significant difference for
Parameter Base 2 h 6 h 1 week
HR [bpm] 113.0 ±12.6 127.5 ±9.2 121.0 ±13.5 119.0 ±8.0
SBP [mmHg] 134 ±5.4 134.3 ±5.3 128.7 ±10.5 129.1 ±7.3
DBP [mmHg] 100.1 ±9.5 97.1 ±9.3 92.5 ±11.3 95.8 ±6.6
LVESV [ml] 11.7 ±5.4 18.5 ±6.4 19.2 ±4.5 22.1 ±8.9
LVEDV [ml] 50.6 ±10.2 55.1 ±10.1 59.5 ±9.2 70.7 ±14.6
LVEF 77.0 ±7.6 69.4 ±8.3 67.5 ±8.1 76.0 ±5.9
FS 44.6 ±7.8 39.0 ±7.1 37.2 ±6.5 44.0 ±4.9
ET-1 [pg/ml] 123.0 ±15.3 138.5 ±8.2 140.9 ±14.8 119.0 ±15.6
MCP-1 [pg/ml] 34.6±2.7 41.2 ±2.9 43.0 ±3.5 34.9 ±3.5
Table I. Changes in systemic haemodynamics and parameters before and after CME66 Arch Med Sci 1, February / 2012
ASBF, PSBF and the ratio of ASBF to PSBF through-
out the study (Figure 3).
Changes of serum monocyte chemotactic 
protein-1 and endothelin-1
Serum MCP-1 level significantly increased 2 h
after CME (2 h vs. baseline p < 0.05), and a further
elevation was observed 6 h after CME (6 h vs. base-
line p < 0.01). Serum ET-1 level was significantly ele-
vated 6 h after CME (6 h vs. baseline p < 0.05).
However, no elevation of serum MCP-1 and ET-1 lev-
els was observed 1 week after CME (p > 0.05 vs.
baseline). Correlation of serum MCP-1 level and LVEF
was not observed in the acute phase or through-
out the study; this also was true for serum ET-1 lev-
el and LVEF. 
Postmortem analysis
In the postmortem analysis, microspheres and
microinfarcts were detected with HE staining at the
anterior myocardial wall. There was a significantly
increased inflammatory response in the microem-
bolized myocardium versus the remote myocardium
(leukocytes: 542.1 ±260/mm2 vs. 231.1 ±126.3/mm2,
p < 0.05). Microspheres were surrounded by a lay-
er of endothelium (Figure 4). As shown in the
TUNEL assay results in Figure 4, the percentage of
apoptotic cardiomyocytes in the anterior myocardi-
um at 1 week (8.13 ±0.99%) after CME was signifi-
cantly higher than that of inferior myocardium (0.12
±0.07%, p < 0.01) (Figure 4). Infarction was not
observed with NBT staining in the short axis sec-
tions.
Discussion
The present study shows that, after CME, CFR
decreased significantly at 6 h and recovered at 
1 week, while LVEF continued to decrease from 2 h
to 6 h and recovered at 1 week. 
Coronary microembolization is a frequent phe-
nomenon in patients undergoing PCI, especially in
those with acute coronary syndrome (ACS). Rup-
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Figure 1. Changes in LVEF, LVEDV and LVESV before
and after CME measured by echocardiography
* vs. base p < 0.05, **vs. base p < 0.01
LVEDV [ml]          LVESV [ml]          LVEF [%]
Figure 2. Changes in left ventricular function before and after CME. A – Base, B – 2 h after CME, C – 6 h after CME,
D – 1 week after CME
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ture of atherosclerotic plaque in an epicardial coro-
nary artery is believed to be the main cause of CME
[13]. Previous studies have shown that CME causes
a transient decrease of coronary blood flow followed
by reactive hyperaemia [14]; the latter is due to the
release of adenosine from endothelial cells after
CME [14]. In the present study, microembolization
induced a reduction of coronary average hyperaemic
peak velocity at 2 h, with a further significant reduc-
tion at 6 h, followed by recovery at 1 week after
CME. Coronary average base peak velocity slightly
increased 2 h after CME and continued to increase
even 1 week after CME. Reduction of CFR was
observed at 6 h after CME. The changes of CFR and
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Figure 3. Changes in myocardial blood flow after CME
ASBF PSBF ASBF/PSBF
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0
Parameter Baseline 2 h  6 h 1 week
Heart rate [bmp] 112.4 ±12.9 104.8 ±26.4 115.0 ±12.2 113.3 ±2.9
Average base peak velocity [cm/s] 8.0 ±1.1 9.2 ±1.5 8.8 ±1.3 9.7 ±1.2
Average hyperaemic peak velocity [cm/s] 16.8 ±4.3 12.3 ±2.60 10.2 ±1.90 15.0 ±3.0
Coronary flow reserve (CFR) 1.8 ±0.3 1.7 ±0.1 1.2 ±0.1 1.6 ±0.2
Average base coronary pressure [mmHg] 115.5 ±39.2 114.7 ±53.3 88.5 ±25.8 116.0 ±34.9
Average hyperaemic coronary pressure [mmHg] 112.5 ±38.0 107.7 ±25.9 88.7 ±26.9 110.3 ±32.8
Table II. Changes in CFR, coronary flow velocity and coronary pressure after CME
Figure 4. HE staining of myocardium and apoptosis before and after CME (400×). A – Posterior myocardium after
CME. B – Anterior myocardium after CME. Microsphere is at the middle. The microsphere is surrounded by inflam-
mation and infarction. C – Posterior myocardium after CME. No apoptosis is observed. D – Anterior myocardium after
CME. Dark nuclear indicates apoptosis after CME
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hyperaemic velocity may be related to changes in
endothelial function after CME, as reflected by
changes in serum ET-1 levels after microemboliza-
tion. Endothelin-1 is a potent vasoconstrictor that
is mainly synthesized by the endothelium [15]; its
vasoconstriction effect is mainly on the microvas-
culature [16]. Thus, ET-1 released from the local
endothelium might lead to sustained microvascu-
lar constriction of the coronary artery [17]. Endothe-
lin-1 can also enhance endothelium permeability
and cause oedema which might induce compres-
sion of small arteries [18]. Furthermore, ET-1 is
proven to be an important modulator of leukocytes
[19], by stimulating accumulation of polymor-
phonuclear (PMN) leukocytes and their adhesion
to the endothelium [19], which might account for
microvascular dysfunction. Recent studies by Nic-
coli et al. also showed that ET-1 levels were elevat-
ed in patients with a first event of acute myocar-
dial infarction undergoing successful primary or
rescue PCI with no reflow [20], and that plasma ET-1
level is able to predict angiographic no-reflow after
successful primary or rescue PCI. In this study,
serum ET-1 level was significantly elevated at 6 h
after CME, which indicates that endothelial dys-
function occurs in the acute phase, as reflected by
reduction of CFR. One week later, elevation of serum
ET-1 level was no longer observed, indicating recov-
ery of endothelial function as a result of CFR recov-
ery. Although changes in CFR were demonstrated
after CME, myocardial blood flow remained unal-
tered throughout the study. This might be due to
the dilation and hyperaemic response of small ves-
sels without microembolization as a consequence
of adenosine released from the endothelium after
CME [14].
In animal studies, repeated CME without 
coronary stenosis induces regional contractile dys-
function without influencing regional myocardial
blood flow [2]. In a sheep model, chronic, severe,
ischaemic heart failure was reported following
repeated CME. The LVEDV increased 73% with the
induction of heart failure and remained 55% above
baseline; left ventricular end diastolic diameter
showed a stable 30% increase, and a stable thin-
ning of the LV wall was observed. It has been
demonstrated that repeated CME leads to left ven-
tricular remodelling lasting for at least 6 months
[21]. Our previous study using MRI indicated that
LVEF decreased at 6 h and recovered 1 week later
in concert with persistent dilation of the left ven-
tricle [7]. In the present study, we demonstrated
that LVEF decreased in the acute phase after CME
and then recovered 1 week later, with a persistent
increase of left ventricular systolic and diastolic vol-
umes. This observation suggests that left ventric-
ular remodelling after CME continues despite car-
diac function recovery 1 week later. 
In the present study, LVEF decreased at 2 h after
CME, which might be due to the inflammatory reac-
tion after microinfarcts rather than apoptosis [22].
The inflammatory reaction observed in the present
study is characterized by infiltration of PMN in the
embolized zone and elevation of serum MCP-1 lev-
els 6 h after CME. We propose that the mechanism
by which left ventricular dilation with preserved
LVEF develops 1 week later relates to neurohumoral
activation and the inflammatory response after
CME [21, 23]. A previous study demonstrated that
a small amount of myocardial injury can lead to
neurohumoral activation with elevation of plasma
angiotensin II and norepinephrine levels [23]. Neu-
rohumoral activation may lead to multiple effects,
including renal salt and water retention which
increase intravascular volume [23, 24], resulting in
elevation of left ventricular end-diastolic volume
and subsequently left ventricular end-diastolic pres-
sure. The present study also showed that the
inflammatory reaction was significantly greater in
the embolized zone than in the control zone. The
infiltration of leukocytes in the embolized zone sug-
gests a role of tumour necrosis factor α [5, 25] and
oxygen free radicals in the progression of left ven-
tricular remodelling [26, 27]. Furthermore, in the
present study, focal ischaemia and necrosis were
observed in the embolized zone, although infarc-
tion was not demonstrated using NBT staining. The
ischaemia and necrosis may be greater than that
in the control zone [2]. Those factors acting togeth-
er may ultimately result in left ventricular remod-
elling. 
A recent study evaluating the changes after CME
measured by magnetic resonance imaging showed
a significant decline in LVEF not only 1 h after injec-
tion, but also 1 week after injection [28]. Differences
between microspheres used in the animal models
may account for the differing results with the cur-
rent study. Larger diameter microspheres might
induce a persistent decline in LVEF.
One of the limitations of this study was that only
a few swine were investigated. However, the sta-
tistical power for the current sample was adequate
to demonstrate a difference in CFR and LVEF before
and after CME. A second limitation is the lack of
control groups. Therefore, it cannot be excluded
that changes in CFR and LVEF are casual. However,
previous studies have demonstrated that changes
seen in this type of animal model resemble those
reported in patients with CME. Thirdly, this animal
model resembles but does not exactly replicate con-
ditions seen in PCI in which diameters of throm-
boemboli are frequently much larger and varied,
and sometimes do not cause myocardial damage.
Besides these limitations, a prolonged observation
period would be warranted to determine the long-
term effects of CME on left ventricular remodelling,Arch Med Sci 1, February / 2012 69
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and further studies are needed to explore the
effects of an antagonist of serum ET-1 on CFR as
well as left ventricular remodelling.
In conclusion, left ventricular dilation with pre-
served LVEF and CFR was observed after CME. This
observation could be of significance for clinical
management of CME in the future. 
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